Ascendis Pharma AS (BSP:A1SN34) Inventories, Raw Materials & Components: R$0 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BSP:A1SN34 Ascendis Pharma AS BSP:A1SN34
55 GF Score
Price R$92.20
! 5 Warning Signs
View Full Analysis

What is Ascendis Pharma AS Inventories, Raw Materials & Components?

Ascendis Pharma AS BSP:A1SN34 55 Inventories, Raw Materials & Components is R$0 Mil as of Mar. 2026. GuruFocus rates BSP:A1SN34 with a GF Score™ of 55/100. The stock has 5 warning signs investors should review.

Ascendis Pharma AS's inventories, raw materials & components for the quarter that ended in Mar. 2026 was R$0 Mil.

Ascendis Pharma AS's quarterly raw materials increased from Sep. 2025 (R$0 Mil) to Dec. 2025 (R$122 Mil) but then declined from Dec. 2025 (R$122 Mil) to Mar. 2026 (R$0 Mil).

Ascendis Pharma AS's annual raw materials increased from Dec. 2023 (R$99 Mil) to Dec. 2024 (R$112 Mil) and increased from Dec. 2024 (R$112 Mil) to Dec. 2025 (R$122 Mil).

Ascendis Pharma AS Inventories, Raw Materials & Components Historical Data

* Premium members only.

The historical data trend for Ascendis Pharma AS's Inventories, Raw Materials & Components can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ascendis Pharma AS Inventories, Raw Materials & Components Chart

Ascendis Pharma AS Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Inventories, Raw Materials & Components
Get a 7-Day Free Trial Premium Member Only Premium Member Only 14.36 0.00 99.20 112.41 121.91

Ascendis Pharma AS Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Inventories, Raw Materials & Components Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 121.91 0.00
BSP:A1SN34
55GF Score
Ascendis Pharma AS BSP:A1SN34
Inventories, Raw Materials & Components is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ascendis Pharma AS Inventories, Raw Materials & Components Calculation

Materials and components scheduled for use in making a product.

What does a Inventories, Raw Materials & Components of R$0 Mil mean?
Ascendis Pharma AS (BSP:A1SN34) has a Inventories, Raw Materials & Components of R$0 Mil as of Mar. 2026. Raw materials are the components a company uses for its main products. View historical data on Ascendis Pharma AS and its competitors.
Is Ascendis Pharma AS's Inventories, Raw Materials & Components too high?
Ascendis Pharma AS's current Inventories, Raw Materials & Components is R$0 Mil. Overall, Ascendis Pharma AS has a GF Score™ of 55/100, reflecting its overall financial health beyond just this single metric.
How does Ascendis Pharma AS's Inventories, Raw Materials & Components compare to JAZZ and BBIO?
Ascendis Pharma AS's Inventories, Raw Materials & Components of R$0 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Raw Materials & Components for a Biotechnology company?
A good Inventories, Raw Materials & Components depends on the Biotechnology industry context. However, Inventories, Raw Materials & Components should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Raw Materials & Components mean?
A high Inventories, Raw Materials & Components can signal that a stock is expensive relative to its fundamentals. Raw materials are the components a company uses for its main products. View historical data on Ascendis Pharma AS and its competitors. Ascendis Pharma AS's current Inventories, Raw Materials & Components is R$0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ascendis Pharma AS stock overvalued right now?
Ascendis Pharma AS (BSP:A1SN34) has a current Inventories, Raw Materials & Components of R$0 Mil. The current Inventories, Raw Materials & Components is R$0 Mil. Ascendis Pharma AS's overall GF Score™ is 55/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Raw Materials & Components calculated?
Inventories, Raw Materials & Components is calculated from a company's financial statements. For Ascendis Pharma AS (BSP:A1SN34), the current Inventories, Raw Materials & Components is R$0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Ascendis Pharma AS Business Description

Other Exchanges ASND:USA
Address Tuborg Boulevard 12, Hellerup, DNK, 2900
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology, which includes TransCon PTH, TransCon CNP, and others. It operates in the United States, Europe, and the rest of the world and derives the majority of its revenue from the United States.
55GF Score

Get the complete analysis for BSP:A1SN34

Inventories, Raw Materials & Components is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

R$92.20
Price